Polycystic Ovarian Syndrome Treatment Market
Polycystic Ovarian Syndrome Treatment Market (PCOS) is expected to reach USD 5.11billion by 2026 at a CAGR of 5.5 % during the forecast period.
The global polycystic ovarian syndrome (pcos) treatment market is segmented drug type, surgery type, and region.
By drug type - oral contraceptives drug, antiandrogen drug, insulin-sensitizing agents, antidepressants drug, an anti-obesity drug.
By surgery type - wedge resection and laparoscopic drilling.
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of the reproductive age and is a heterogeneous disorder of unknown etiology resulting in overproduction of androgens, primarily from the ovary, and is associated with insulin resistance (IR). The most common symptoms of PCOS range from menstrual disorders, infertility, and hyperandrogenemia to metabolic syndrome (MS).
Major Market Drivers:
- Sedentary lifestyle and faulty dietary habits
- Rising incidence of the polycystic ovarian syndrome
- Recent technological advances
Restraints:
- Lack of FDA approved drugs
- Increasing side effects associated with generics
Polycystic Ovarian Syndrome Treatment Market (PCOS)
Strategic Developments in the Polycystic Ovarian Syndrome (PCOS) Treatment Market:
In January 2016, AstraZeneca (U.K) announced that they have started startup for women health treatment and invested 62 US Million dollars in drug development of poly cystic ovarian disorder.
Teva Pharmaceutical Industries Limited has used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The North American region is playing the principal role in the polycystic ovarian syndrome (pcos) treatment market due to a sedentary lifestyle and faulty dietary habits and rising incidence of a polycystic ovarian syndrome. Though, Asia-Pacific will be the second major market in the proximate future followed by LAMEA region. The presence of innovative medical advanced technology and the presence of a large target patient pool.
For more information visit:
Scope of the Polycystic Ovarian Syndrome Treatment Market (PCOS) Report
Polycystic Ovarian Syndrome Treatment Market (PCOS), by drug type
- Oral contraceptives drug
- Antiandrogen drug
- Insulin-sensitizing agents
- Antidepressants drug
- Anti-obesity drug
Polycystic Ovarian Syndrome Treatment Market (PCOS), by surgery type
- wedge resection
- laparoscopic drilling
Polycystic Ovarian Syndrome Treatment Market (PCOS), By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Key Players in Polycystic Ovarian Syndrome Treatment Market (PCOS)
- Sanofi
- Novartis AG
- Teva Pharmaceutical Industries Limited
- Addex Therapeutics Ltd.
- BIOCAD
- Merck KGaA
- AstraZeneca plc.
- Bristol Myers Squibb Co.
- Ferring Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals, Inc.
Reasons to Purchase this Report:
- Current and future of global deep polycystic ovarian syndrome (pcos) treatment market, the outlook in the developed and emerging markets.
- The segment that is predictable to lead the market as well as the segment which holds highest CAGR in the forecast period.
- Regions/countries that are expected to witness the fastest growth rates during the forecast period.
- The latest innovative developments, market shares, and strategies that are employed by the major market players.
This Report Is Submitted By Maximize Market Research
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Address: Maharashtra 411051, India.
Contact:+919607065656